| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |